Gesamtpreis (1 Artikel Artikel):
Versandziel:
mellinghoff ingo (31 Ergebnisse)
Direkt zu den wichtigsten Suchergebnissen
Suchfilter
Produktart
- Alle Product Types
- Bücher (31)
- Magazine & Zeitschriften (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Comics (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Noten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Kunst, Grafik & Poster (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Fotografien (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Karten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Manuskripte & Papierantiquitäten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Zustand Mehr dazu
- Neu (25)
- Wie Neu, Sehr Gut oder Gut Bis Sehr Gut (6)
- Gut oder Befriedigend (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Ausreichend oder Schlecht (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Wie beschrieben (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Weitere Eigenschaften
- Erstausgabe (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Signiert (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Schutzumschlag (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Angebotsfoto (13)
- Keine Print-on-Demand Angebote (21)
Sprache (1)
Gratisversand
- Kostenloser Versand nach USA (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Land des Verkäufers
Verkäuferbewertung
-
Therapeutic Kinase Inhibitors (Current Topics in Microbiology and Immunology, 355)
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 163,72
EUR 13,81 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
-
Therapeutic Kinase Inhibitors (Current Topics in Microbiology and Immunology, 355)
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 163,72
EUR 13,81 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 163,70
EUR 17,30 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: As New. Unread book in perfect condition.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 163,70
EUR 17,30 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbZustand: New.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
EUR 180,48
EUR 2,30 Versand
Versand innerhalb von USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg, 2014
ISBN 10: 3642445802 ISBN 13: 9783642445804
EUR 136,16
EUR 48,99 Versand
Versand von Deutschland nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg, 2012
ISBN 10: 3642282954 ISBN 13: 9783642282959
EUR 136,16
EUR 48,99 Versand
Versand von Deutschland nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 180,96
EUR 17,30 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
-
Zustand: New. pp. 246.
-
Zustand: New. pp. 246 Index.
-
Taschenbuch. Zustand: Neu. Therapeutic Kinase Inhibitors | Ingo K. Mellinghoff (u. a.) | Taschenbuch | Current Topics in Microbiology and Immunology | x | Englisch | 2014 | Springer | EAN 9783642445804 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg, Springer Berlin Heidelberg, 2012
ISBN 10: 3642282954 ISBN 13: 9783642282959
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
-
Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as ¿chemotherapy¿ and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
-
Therapeutic Kinase Inhibitors: 355 (Current Topics in Microbiology and Immunology)
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 234,52
EUR 11,53 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. reprint edition. 234 pages. 8.75x6.00x0.50 inches. In Stock.
-
Therapeutic Kinase Inhibitors: Vol 355
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 235,97
EUR 11,53 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 2012 edition. 244 pages. 9.25x6.25x0.75 inches. In Stock.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 267,23
EUR 17,30 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
-
Therapeutic Kinase Inhibitors (Current Topics in Microbiology and Immunology, 355)
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 257,74
EUR 28,83 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
EUR 292,08
EUR 2,30 Versand
Versand innerhalb von USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
-
Therapeutic Kinase Inhibitors (eng)
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Verkäuferbewertung 3 von 5 Sternen
EUR 126,26
EUR 5,50 Versand
Versand von Italien nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
-
Therapeutic Kinase Inhibitors (eng)
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Verkäuferbewertung 3 von 5 Sternen
EUR 126,26
EUR 5,50 Versand
Versand von Italien nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg Apr 2014, 2014
ISBN 10: 3642445802 ISBN 13: 9783642445804
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert. 244 pp. Englisch.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg Mrz 2012, 2012
ISBN 10: 3642282954 ISBN 13: 9783642282959
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert. 244 pp. Englisch.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 212,33
EUR 7,50 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 246 30 Illus. (21 Col.).
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg, Springer Berlin Heidelberg Mär 2012, 2012
ISBN 10: 3642282954 ISBN 13: 9783642282959
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as ¿chemotherapy¿ and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates.This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 244 pp. Englisch.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologySprache: Englisch
Verlag: Springer Berlin Heidelberg, Springer Berlin Heidelberg Apr 2014, 2014
ISBN 10: 3642445802 ISBN 13: 9783642445804
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as ¿chemotherapy¿ and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 244 pp. Englisch.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. PRINT ON DEMAND pp. 246.
-
Therapeutic Kinase Inhibitors
Buch 151 von 322: Current Topics in Microbiology and ImmunologyAnbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 223,01
EUR 7,50 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 4 verfügbar
In den WarenkorbZustand: New. Print on Demand pp. 246 30 Illus. (21 Col.).
